Position in ELAN
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$1,437,570
+$1,011,510 QoQ
Shares Held
60,074
+75.0% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ELAN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026ALLSTATE CORP holds $15,014,275 across 8 Drug Manufacturers - Specialty & Generic names. ELAN ranks #5 (9.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
45,809 | $5,415,081 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
4,710 | $2,792,935 | |
| 3 | VTRS |
Viatris Inc
|
153,602 | $2,075,163 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
12,349 | $1,626,857 | |
| 5 | ELAN |
Elanco Animal Health Inc
This page
|
60,074 | $1,437,570 | |
| 6 | ALKS |
Alkermes plc.
|
29,154 | $1,030,885 | |
| 7 | TLRY |
Tilray Brands, Inc.
|
56,727 | $367,023 | |
| 8 | AMRX |
Amneal Pharmaceuticals, Inc.
|
21,622 | $268,761 |
All Filings in ELAN
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,437,570 | 60,074 | Shares | Sole | 2026-05-11 | |
| 2022-09-30 | $426,060 | 34,332 | Shares | Sole | 2022-11-14 | |
| 2021-12-31 | $1,803,549 | 63,550 | Shares | Sole | 2022-02-15 | |
| 2021-06-30 | $262,187 | 7,558 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $263,135 | 8,935 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $239,226 | 7,800 | Shares | Sole | 2021-02-12 | |
| 2020-03-31 | $230,102 | 10,277 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||